NDC 87216-0100
Emcitate 350 ug tablet, for suspension
On the label: Rare Thyroid Therapeutics International AB.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Cenexi | Osny, France | Makes it | Problems found, fixed voluntarilyDec 14, 2022 · 3 inspections |
| Dottikon Exclusive Synthesis Ag | Dottikon, Switzerland | Makes the active ingredient | Problems found, fixed voluntarilyFeb 7, 2025 · 5 inspections |
| Jetpharma SA | Balerna, Switzerland | Mills it | No problems foundJun 23, 2023 · 6 inspections |
| Siegfried Barbera, SL | Barberà del Vallès, Spain | Packages it | Problems found, fixed voluntarilyMar 30, 2023 · 3 inspections |
| Simec AG | Oftringen, Switzerland | Tests it | No problems foundJun 16, 2023 · 1 inspection |
Product details
- Generic drug
- Tiratricol: every company that makes it
- Form
- tablet, for suspension, oral
- Strength
- 350 ug
- Approval
- NDA NDA220963
- On the market since
- Oct 26, 2026
- Package NDCs
87216-0100-087216-0100-1- Official label
- DailyMed (National Library of Medicine), updated Oct 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?